BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
See today's BioWorld MedTech
Home
» Amedica seeks 510(k) clearance for Valeo CCsC interebody fusion device
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Amedica seeks 510(k) clearance for Valeo CCsC interebody fusion device
Feb. 13, 2015
By
Amanda Pedersen
No Comments
Amedica (Salt Lake City), reported Thursday that it has filed a submission for FDA 510(k) clearance of its Valeo C Interbody with CsC Osteo-Conductive Scaffolding (Valeo CCsC) relating to its composite silicon nitride spinal interbody devices.
BioWorld MedTech